Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence KVQWKVDNALQSGNSQESV
Primary information
sequence IDSeq_4484
Peptide sequenceKVQWKVDNALQSGNSQESV
CancerPDF_ID CancerPDF_ID5634, CancerPDF_ID5635, CancerPDF_ID5636, CancerPDF_ID5637, CancerPDF_ID5638, CancerPDF_ID5639, CancerPDF_ID5640, CancerPDF_ID5641, CancerPDF_ID5642,
PMID24982608,24982608,24982608,24982608,24982608,24982608,24982608,24982608,24982608
Protein Name26 kDa protein,26 kDa protein,Anti-RhD monoclonal T125 kappa light chain,Ig kappa chain C region,Ig kappa chain C region,IGKat protein,IGKat protein,Putative uncharacterized protein,Putative uncharacterized protein IGKC
UniprotKB Entry NameNA,NA,Q5EFE6_HUMAN,IGKC_HUMAN,IGKC_HUMAN,Q6PJF2_HUMAN,Q6PJF2_HUMAN,NA,NA
FluidUrine,Urine,Urine,Urine,Urine,Urine,Urine,Urine,Urine
M/ZNA,NA,NA,NA,NA,NA,NA,NA,NA
ChargeNA,NA,NA,NA,NA,NA,NA,NA,NA
Mass (in Da)NA,NA,NA,NA,NA,NA,NA,NA,NA
fdrNA,NA,NA,NA,NA,NA,NA,NA,NA
Profiling TechniqueNano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS
Peptide Identification techniqueMS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS
Quantification TechniqueNA,NA,NA,NA,NA,NA,NA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free
FDR0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01
CancerPDF_ID CancerPDF_ID5634, CancerPDF_ID5635, CancerPDF_ID5636, CancerPDF_ID5637, CancerPDF_ID5638, CancerPDF_ID5639, CancerPDF_ID5640, CancerPDF_ID5641, CancerPDF_ID5642,
p-ValueNA,NA,NA,NA,NA,NA,NA,NA,NA
Software"GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT"
Length17,17,17,17,17,17,17,17,17
Cancer TypeOvarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer
DatabaseIPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database
ModificationNA,NA,NA,NA,NA,NA,NA,NA,NA
Number of Patients6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals
RegulationUniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients
ValidationNA,NA,NA,NA,NA,NA,NA,NA,NA
SensitivityNA,NA,NA,NA,NA,NA,NA,NA,NA
SpecificityNA,NA,NA,NA,NA,NA,NA,NA,NA
AccuracyNA,NA,NA,NA,NA,NA,NA,NA,NA
Peptide AtlasNA
IEDB